Background: Previous study reported jailed strut at side branch orifice (SO) may be a cause of delayed tissue coverage and thrombus formation after single stenting to bifurcation. We assessed the neointimal coverage of jailed strut in four different types of drug-eluting stent (DES). Methods: Total of 78 true bifurcation lesions treated by single stenting using 27 sirolimus-eluting stent (SES), 17 paclitaxel-eluting stent (PES), 21 everolimus-eluting stent (EES), and 14 biolimus-eluting stent (BES) without final kissing inflation underwent optical coherence tomography imaging at mid-term follow up after implantation (8AE2 months). We evaluated neointimal thickness on jailed strut (Jail-NIT), whole tissue thickness surrounding jailed strut (jailed struts complex; JSC) and frequency of thrombus attachment. We also classified JSC into four groups according to the surface (regular / irregular) and morphology (homogeneous / heterogeneous). Results: Jail-NIT was thicker in SES and thinner in PES (SES: 68.2AE47.1mm, PES: 25.6AE36.3mm, EES: 57.8AE44.6mm, BES 60.1AE29.2mm, P<0.05). Thickness of JSC in SES showed thicker than other three DES. JSC in EES and BES showed predominantly regular and homogeneous compared with that in SES and PES (figure). Thrombus on jailed strut was most frequently detected in SES (SES: 9/27, PES: 4/17, EES: 1/21, BES: 1/13 P<0.05).
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Conclusions:
Although SES and PES show various tissue attachment on jailed strut with higher incidence of thrombus, EES and BES seems to develop less thrombogenic stable neointimal coverage. This suggests a potential benefit of EES or BES implantation to bifurcation lesion.
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First Background: Biodegradable polymer drug-eluting stents (BPDES) have been developed to address the risk of stent thrombosis. The EXCEL stent (JW Medical Systems, Weihai, China) features an abluminal PLA drug carrier which enables a 6-9 month 100% drug release in vivo. The BuMA stent (Sino Medical, Tianjin, China) features an electro-grafting (eG) base layer and a PLGA drug carrier. The eG layer secures adhesion of the biodegradable PLGA coating as a result of the interdigitation, and the PLGA coating ensures 100% drug release profile in 30 days. We aimed to compare 3-month neointimal formation by using optical coherence tomography (OCT) between the two BPDES, which are both based on the stainless steel platform, releasing sirolimus, but with different coating designs. Methods: Patients with clinical evidence of myocardial ischemia were recruited in this prospective, single center, randomized, non-inferiority trial in 1:1 fashion. All patients were required to undergo OCT and angiographic follow-up at 3 months after intervention. Neointimal growth was analyzed at each stent strut of cross-sectional OCT images with 0.5mm intervals. The primary endpoint is the proportion of fully covered stent struts (%) at 3 months. Secondary endpoints include neointimal thickness, stent strut malapposition, and angiographic late lumen loss. If non-inferiority of the primary endpoint is met, superiority test will be performed. Results: Eighty patients were randomly allocated to either BuMA (n¼40) or EXCEL (n¼40) group. There were no significant differences (all p<0.05) with respect to baseline characteristics, procedural results, and 1-month clinical outcomes between the two groups ( Background: Pathological studies report that acute ST-segment elevation myocardial infarction (STEMI) is caused not only by plaque rupture but also by other causes, such as erosion. We sought to assess whether coronary plaque rupture at culprit lesions is associated with infarct size in patients with STEMI. Some patients with STEMI have large infarcts despite early reperfusion. Whether culprit plaque morphology impacts infarct size or not remains unknown. Methods: Patients who had a first STEMI with reperfusion within 12 hours after onset were enrolled and divided into 2 groups according to the presence or absence of plaque rupture at the culprit lesion as defined by Optical Coherence Tomography(OCT): patients with rupture (n ¼68) and without rupture (n ¼ 35).
Results: Patients with plaque rupture had higher peak creatine kinase levels (3755 AE2826 vs. 1768 AE1593 IU/l ; p < 0.0001) ,creatine kinase-myocardial band were higher (328 AE 206 vs. 180 AE 175 IU/l ; p ¼ 0.0002). And infarct sizes detected by contrast-enhanced cardiac magnetic resonance were higher (19.3 AE 11.9 vs. 10.1 AE 6.0 % ; p <0.0001) in ruptured group than non-ruptured group. Transmural extent of infarction Grade (TEI-Grade) was grater (p ¼ 0.0001) in ruptured group. The presence of microvascular obstruction (MVO) was higher (39 vs. 19% ; p ¼ 0.0261) in ruptured group.
Conclusions: Plaque rupture is associated with morphologic characteristics of vulnerable lesions, as well as with larger infarcts size. 
